BI
BVF Inc’s Kymera Therapeutics KYMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240M | Buy |
5,502,710
+340,909
| +7% | +$14.9M | 8.58% | 2 |
|
|
2025
Q1 | $141M | Hold |
5,161,801
| – | – | 5.76% | 4 |
|
|
2024
Q4 | $208M | Hold |
5,161,801
| – | – | 7.04% | 2 |
|
|
2024
Q3 | $244M | Hold |
5,161,801
| – | – | 7.15% | 2 |
|
|
2024
Q2 | $154M | Hold |
5,161,801
| – | – | 4.32% | 3 |
|
|
2024
Q1 | $208M | Hold |
5,161,801
| – | – | 5.7% | 2 |
|
|
2023
Q4 | $131M | Buy |
5,161,801
+422,797
| +9% | +$10.8M | 3.29% | 5 |
|
|
2023
Q3 | $65.9M | Hold |
4,739,004
| – | – | 1.78% | 14 |
|
|
2023
Q2 | $109M | Hold |
4,739,004
| – | – | 3.04% | 7 |
|
|
2023
Q1 | $140M | Buy |
4,739,004
+46,400
| +1% | +$1.37M | 5.13% | 2 |
|
|
2022
Q4 | $117M | Hold |
4,692,604
| – | – | 4.94% | 4 |
|
|
2022
Q3 | $102M | Buy |
4,692,604
+553,846
| +13% | +$12.1M | 4.22% | 4 |
|
|
2022
Q2 | $81.5M | Buy |
4,138,758
+552,100
| +15% | +$10.9M | 3.94% | 7 |
|
|
2022
Q1 | $152M | Buy |
3,586,658
+406,000
| +13% | +$17.2M | 6.07% | 2 |
|
|
2021
Q4 | $202M | Hold |
3,180,658
| – | – | 7.33% | 2 |
|
|
2021
Q3 | $187M | Buy |
3,180,658
+550,000
| +21% | +$32.3M | 7.29% | 2 |
|
|
2021
Q2 | $128M | Hold |
2,630,658
| – | – | 4.78% | 6 |
|
|
2021
Q1 | $102M | Hold |
2,630,658
| – | – | 3.83% | 8 |
|
|
2020
Q4 | $163M | Hold |
2,630,658
| – | – | 6.42% | 3 |
|
|
2020
Q3 | $85M | Buy |
+2,630,658
| New | +$85M | 4.63% | 4 |
|